Skip to main content
BIONIME logo

BIONIME — Investor Relations & Filings

Ticker · 4737 ISIN · TW0004737002 TW Manufacturing
Open in API
Filings indexed 1,740 across all filing types
Latest filing 2023-06-08 Fund Information / Fact…
Country TW Taiwan
Listing TW 4737

About BIONIME

www.bionime.com

Bionime Corporation is a biotechnology firm specializing in the research, design, and manufacturing of comprehensive blood glucose management systems. The company develops high-precision monitoring solutions for both personal home use and professional medical environments, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and Point-of-Care Testing (POCT). Under its proprietary brand, RIGHTEST, Bionime integrates medical, chemical, electronic, and precision machinery expertise to deliver products that rival international standards. A core component of its offering is a cloud-based management ecosystem powered by IoT digital solutions, which synchronizes medical data with patient care services. With over 480 core patents in CGM technology and a commitment to Industry 4.0 smart production, Bionime focuses on enhancing diabetes care through technical innovation and a human-centered approach to health monitoring.

Recent filings

Filing Released Lang Actions
112年5月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 華廣, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or audit information. The length is short (771 characters), and it does not appear to be a full financial report but rather a brief financial data summary. This fits best with a Fund Information / Factsheet (FS) category, which is a brief summary of key company financials and market info.
2023-06-08 Chinese
112年05月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, independent directors, and senior management. It focuses on insider shareholdings and pledges, with no financial statements, earnings data, or meeting results. The content is consistent with a report on insider share transactions or holdings. Given the focus on insider shareholdings and the absence of other report types, this fits the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives. The document length is about 3111 characters, which is sufficient for a detailed insider shareholding report. Therefore, the classification is DIRS with high confidence.
2023-06-06 Chinese
112年05月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, senior management, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares. The content is focused on insider share transactions and holdings rather than financial results, governance policies, or meeting materials. There is no indication of a full financial report, earnings release, or meeting announcement. The document is not a proxy statement or voting result announcement. It is a report of personal share transactions and holdings by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data on insider shareholdings, confirming it is not a brief announcement or certification. Therefore, the appropriate classification is DIRS with high confidence.
2023-06-06 Chinese
112年05月僑外投資持股
Major Shareholding Notification Classification · 95% confidence The document is a statistical table showing the shareholding situation of overseas and mainland China investors, including changes before and after a shareholders' meeting date. It contains no financial statements, management discussion, or detailed report content. The document length is short (1073 characters) and it primarily reports shareholding data related to a shareholders' meeting. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or shareholding statistics.
2023-05-19 Chinese
112年第1季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by the company 華廣. It includes specific financial figures, investment methods, and regulatory limits, which are typical of a regulatory compliance disclosure rather than a full financial report. The document length is short (1418 characters), and it does not contain comprehensive financial statements or management discussion. It appears to be a regulatory filing related to investment disclosures, likely submitted to a regulatory body for compliance purposes. There is no indication that this is an annual or quarterly report, audit report, or earnings release. It is not a report publication announcement since it contains substantive data. Therefore, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2023-05-12 Chinese
112年第1季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure related to investment holdings in overseas subsidiaries for the first quarter of the 112th year (likely a fiscal period). It contains tabulated data on shareholding percentages, original investment amounts, investment balances, and recognized investment gains or losses. The document length is only 1009 characters, which is quite short and does not contain comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure or announcement of investment holdings rather than a full interim or annual report. There is no indication that this is a full quarterly or annual report, nor is it a certification or voting result. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2023-05-12 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.